Royal Marsden NHS Foundation Trust: New Targeted Ovarian Cancer Treatment Available for NHS Patients for the First Time in Over 20 Years
June 06, 2026
June 06, 2026
LONDON, England, June 6 -- The Royal Marsden National Health Service Foundation Trust issued the following news:
* * *
New targeted ovarian cancer treatment available for NHS patients for the first time in over 20 years
The NICE recommendation is based on findings from the international Phase III MIRASOL trial, which was led in the UK by The Royal Marsden.
*
A team of Royal Marsden researchers have welcomed the news that a new life . . .
* * *
New targeted ovarian cancer treatment available for NHS patients for the first time in over 20 years
The NICE recommendation is based on findings from the international Phase III MIRASOL trial, which was led in the UK by The Royal Marsden.
*
A team of Royal Marsden researchers have welcomed the news that a new life . . .